These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 32882916)

  • 1. Genomics and Functional Genomics of Malignant Pleural Mesothelioma.
    Cakiroglu E; Senturk S
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32882916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma.
    Blondy T; d'Almeida SM; Briolay T; Tabiasco J; Meiller C; Chéné AL; Cellerin L; Deshayes S; Delneste Y; Fonteneau JF; Boisgerault N; Bennouna J; Grégoire M; Jean D; Blanquart C
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of extracellular matrix constituents and cell adhesion molecules between malignant pleural mesothelioma and mesothelial hyperplasia.
    Alì G; Borrelli N; Riccardo G; Proietti A; Pelliccioni S; Niccoli C; Boldrini L; Lucchi M; Mussi A; Fontanini G
    J Thorac Oncol; 2013 Nov; 8(11):1389-95. PubMed ID: 24084442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic characterization of malignant pleural mesothelioma and associated clinical outcomes.
    Markowitz P; Patel M; Groisberg R; Aisner J; Jabbour SK; De S; Ganesan S; Malhotra J
    Cancer Treat Res Commun; 2020; 25():100232. PubMed ID: 33166854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma.
    Greillier L; Tounsi A; Berenguer-Daizé C; Dussault N; Delfino C; Benyahia Z; Cayol M; Mabrouk K; Garcia S; Martin PM; Barlesi F; Ouafik L
    J Thorac Oncol; 2016 Jan; 11(1):94-107. PubMed ID: 26762744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in lung and thoracic pathology: molecular advances in the classification of pleural mesotheliomas.
    Fernandez-Cuesta L; Mangiante L; Alcala N; Foll M
    Virchows Arch; 2021 Jan; 478(1):73-80. PubMed ID: 33411030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNAs and related molecular basis in malignant pleural mesothelioma: Challenges and potential.
    Xu X; Li H; Xie M; Zhou Z; Wang D; Mao W
    Crit Rev Oncol Hematol; 2023 Jun; 186():104012. PubMed ID: 37116816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological and molecular biological approaches to early mesothelioma.
    Tsujimura T; Torii I; Sato A; Song M; Fukuoka K; Hasegawa S; Nakano T
    Int J Clin Oncol; 2012 Feb; 17(1):40-7. PubMed ID: 22237727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival.
    Quetel L; Meiller C; Assié JB; Blum Y; Imbeaud S; Montagne F; Tranchant R; de Wolf J; Caruso S; Copin MC; Hofman V; Gibault L; Badoual C; Pintilie E; Hofman P; Monnet I; Scherpereel A; Le Pimpec-Barthes F; Zucman-Rossi J; Jaurand MC; Jean D
    Mol Oncol; 2020 Jun; 14(6):1207-1223. PubMed ID: 32083805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic analysis in short- and long-term patients with malignant pleura mesothelioma treated with palliative chemotherapy.
    Torricelli F; Saxena A; Nuamah R; Neat M; Harling L; Ng W; Spicer J; Ciarrocchi A; Bille A
    Eur J Cancer; 2020 Jun; 132():104-111. PubMed ID: 32339978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs dysregulation in human malignant pleural mesothelioma.
    Balatti V; Maniero S; Ferracin M; Veronese A; Negrini M; Ferrocci G; Martini F; Tognon MG
    J Thorac Oncol; 2011 May; 6(5):844-51. PubMed ID: 21358347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects.
    Guarrera S; Viberti C; Cugliari G; Allione A; Casalone E; Betti M; Ferrante D; Aspesi A; Casadio C; Grosso F; Libener R; Piccolini E; Mirabelli D; Dianzani I; Magnani C; Matullo G
    J Thorac Oncol; 2019 Mar; 14(3):527-539. PubMed ID: 30408567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup.
    Pirker C; Bilecz A; Grusch M; Mohr T; Heidenreich B; Laszlo V; Stockhammer P; Lötsch-Gojo D; Gojo J; Gabler L; Spiegl-Kreinecker S; Dome B; Steindl A; Klikovits T; Hoda MA; Jakopovic M; Samarzija M; Mohorcic K; Kern I; Kiesel B; Brcic L; Oberndorfer F; Müllauer L; Klepetko W; Schmidt WM; Kumar R; Hegedus B; Berger W
    Clin Cancer Res; 2020 Jul; 26(14):3819-3830. PubMed ID: 32317288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of several biomarkers for the patients with malignant pleural mesothelioma.
    Liu H; Wu L; Ji K; Wang W
    Tumour Biol; 2015 Sep; 36(10):7375-84. PubMed ID: 26361957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Molecular Basis of Malignant Pleural Mesothelioma.
    Wadowski B; De Rienzo A; Bueno R
    Thorac Surg Clin; 2020 Nov; 30(4):383-393. PubMed ID: 33012428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New therapeutic strategies for malignant pleural mesothelioma.
    Bonelli MA; Fumarola C; La Monica S; Alfieri R
    Biochem Pharmacol; 2017 Jan; 123():8-18. PubMed ID: 27431778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Epithelial-to-Mesenchymal Transition (EMT) in the Development and Metastasis of Malignant Pleural Mesothelioma.
    Ramundo V; Zanirato G; Aldieri E
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesothelioma Biomarkers: Discovery in Search of Validation.
    Pass HI; Alimi M; Carbone M; Yang H; Goparaju CM
    Thorac Surg Clin; 2020 Nov; 30(4):395-423. PubMed ID: 33012429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD26-mediated regulation of periostin expression contributes to migration and invasion of malignant pleural mesothelioma cells.
    Komiya E; Ohnuma K; Yamazaki H; Hatano R; Iwata S; Okamoto T; Dang NH; Yamada T; Morimoto C
    Biochem Biophys Res Commun; 2014 May; 447(4):609-15. PubMed ID: 24747072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel PDX modeling strategy and its application in metabolomics study for malignant pleural mesothelioma.
    Chen Z; Yang C; Guo Z; Song S; Gao Y; Wang D; Mao W; Liu J
    BMC Cancer; 2021 Nov; 21(1):1235. PubMed ID: 34789172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.